Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

35 questions · 37 findings · 6 reviews · Headline outcomes only

No studies found 9 · 24.3%GRADE not reported 0 · 0%Very low 7 · 18.9%Low 10 · 27%Moderate 11 · 29.7%High 0 · 0%

Topical clindamycin vs placebo

Adverse effects (non‐serious) · participants with hidradenitis suppurativa

Topical clindamycin showed no clear difference in adverse effects (non‐serious) compared with placebo (moderate certainty).

1 finding from 1 review

Clindamycin plus aminoglycoside vs other regimens

Severe complication ‐ lincosamides versus cephalosporins · women with postpartum endometritis

It is very uncertain whether clindamycin plus aminoglycoside changes severe complication ‐ lincosamides versus cephalosporins compared with any other regimen (very low certainty).

1 finding from 1 review

Clindamycin plus aminoglycoside vs other regimens

Wound infection · women with postpartum endometritis

Clindamycin plus aminoglycoside may leads to lower wound infection ‐ lincosamides versus cephalosporins compared with any other regimen (low certainty).

2 findings from 1 review

Clindamycin plus aminoglycoside vs other regimens

Allergic reaction · women with postpartum endometritis

Clindamycin plus aminoglycoside showed no clear difference in allergic reaction ‐ lincosamides versus cephalosporins compared with any other regimen (low certainty).

2 findings from 1 review

Clindamycin phosphate 1.2% + tretinoin 0.025% gel vs placebo

Proportion of participants with adverse event · Participants with rosacea

Clindamycin phosphate 1.2% + tretinoin 0.025% gel probably leads to higher proportion of participants with adverse event compared with placebo (moderate certainty).

1 finding from 1 review

Clindamycin phosphate 1.2% + tretinoin 0.025% gel vs placebo

Assessment of erythema or telangiectasia · Participants with rosacea

Clindamycin phosphate 1.2% + tretinoin 0.025% gel showed no clear difference in assessment of erythema or telangiectasia compared with placebo (moderate certainty).

1 finding from 1 review